𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zebrafish: An Emerging Model System for Human Disease and Drug Discovery

✍ Scribed by Kari, G; Rodeck, U; Dicker, A P


Book ID
110020082
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
262 KB
Volume
82
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Xenopus: An emerging model for studying
✍ Erin Kaltenbrun; Panna Tandon; Nirav M. Amin; Lauren Waldron; Chris Showell; Fra πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 202 KB

## Abstract Congenital heart defects affect nearly 1% of all newborns and are a significant cause of infant death. Clinical studies have identified a number of congenital heart syndromes associated with mutations in genes that are involved in the complex process of cardiogenesis. The African clawed

Model Organisms in Drug Discovery || Gro
✍ Carroll, Pamela M.; Fitzgerald, Kevin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley & Sons, Ltd 🌐 English βš– 426 KB πŸ‘ 2 views

Yeast has great utility as a surrogate system to study aspects of mammalian biology. This utility extends to the drug discovery process, where yeast has been used to reveal the mechanism of action of compounds, to discover and characterize components of signaling pathways and to dissect protein func

Human pluripotent stem cells for disease
✍ Yves Maury; Morgane Gauthier; Marc Peschanski; CΓ©cile Martinat πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 362 KB πŸ‘ 2 views

## Abstract Considerable hope surrounds the use of disease‐specific pluripotent stem cells to generate models of human disease allowing exploration of pathological mechanisms and search for new treatments. Disease‐specific human embryonic stem cells were the first to provide a useful source for stu

Model Organisms in Drug Discovery || Dro
✍ Carroll, Pamela M.; Fitzgerald, Kevin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley & Sons, Ltd 🌐 English βš– 595 KB

Genetic and genomic research in model organisms has tremendously accelerated our understanding of the basic biological processes that lie at the heart of human disease. The genetic dissection of disease-relevant signaling pathways in Drosophila offers an ideal tool to identify novel drug targets for